CoChat

Evaluation of cerebrospinal fluid phosphorylated tau231 as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia

Open access
Kiđemet‐Piskač, Spomenka, Babić Leko, Mirjana, Blažeković, Antonela, Langer Horvat, Lea, Klepac, Nataša, Sonicki, Zdenko, Kolenc, Danijela, Hof, Patrick R., Boban, Marina, Mimica, Ninoslav, Borovečki, Fran, Šimić, Goran · 2018 · CNS Neuroscience & Therapeutics
Cited by 37

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Summary: Background: The diagnosis of either Alzheimer's disease (AD) or vascular dementia (VaD) is still largely based on clinical guidelines and exclusion of other diseases that may lead to dementia. Aims: In this study, we assessed whether the use of sensitive and specific biomarkers such as phosphorylated tau proteins could contribute to an earlier and more accurate diagnosis of AD and VaD, as well as to their differentiation. Material and methods: A total of 198 patients, of which 152 had AD, 28 VaD, and 18 were healthy controls (HC), were included in the analyses. We analyzed cerebrospinal fluid (CSF) levels of total tau protein (t‐tau), tau protein phosphorylated at threonine 231 (p‐tau 231), and factor score (FS) determined by combination of p‐tau 231 and Mini‐Mental State Examination (MMSE) in patients with AD and VaD, as well as in HC. We tested the diagnostic accuracy of these biomarkers in the CSF and FS (p‐tau 231, MMSE) in differentiating AD from VaD and HC. Results: Total tau levels were significantly elevated in subjects with AD compared to HC, as well as in VaD subjects compared to HC. Discussion: p‐tau 231 levels were significantly higher in patients with ADvsHC as well in patients with VaD vsHC. p‐tau 231 levels did not distinguish AD from VaD patients. Importantly, FS(p‐tau 231 and MMSE) showed statistically significant differences in the distribution of subjects with AD and VaD. Conclusion: These results indicate that FS (p‐tau 231 and MMSE) has a strong potential to provide an early distinction between AD and VaD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/cns.12814

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 37

Metadata

Authors
Kiđemet‐Piskač, S., Babić Leko, M., Blažeković, A., Langer Horvat, L., Klepac, N., Sonicki, Z., Kolenc, D., Hof, P. R., Boban, M., Mimica, N., Borovečki, F., & Šimić, G.
Venue
CNS Neuroscience & Therapeutics
Publisher
Wiley
Published
2018-02-17
Volume
24
Issue
8
Pages
734-740
ISSN
  • 1755-5930 (ISSN-L)
  • 1755-5949
OpenAlex
W2789319137
Cited by
37
References
5
FWCI
2.95
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evaluation of cerebrospinal fluid phosphorylated tau231 as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia. https://app.cochat.ai/papers/10.1111/cns.12814
The paper
Kiđemet‐Piskač, S., Babić Leko, M., Blažeković, A., Langer Horvat, L., Klepac, N., Sonicki, Z., Kolenc, D., Hof, P. R., Boban, M., Mimica, N., Borovečki, F., & Šimić, G. (2018). Evaluation of cerebrospinal fluid phosphorylated tau231 as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.12814

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.